Neurocrine Biosciences Inc (NBIX) Com Stk NPV (CDI)

Sell:$108.83Buy:$149.79$0.46 (0.34%)

NASDAQ:1.03%
Market closed | Prices delayed by at least 15 minutes
Sell:$108.83
Buy:$149.79
Change:$0.46 (0.34%)
Market closed | Prices delayed by at least 15 minutes
Sell:$108.83
Buy:$149.79
Change:$0.46 (0.34%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 December 2024
Ingrid DelaetChief Level Officer
Sell
Option/Award related
1,091$135.00$147,285.002,507
29 November 2024
Jude OnyiaChief Level Officer
Sell
Tax related
2,331$126.29$294,372.6715,449
3 October 2024
David Warren (Dave) BoyerChief Level Officer
Sell
Regular sell transaction (market)
1,295$113.66$147,189.70377
13 September 2024
David Warren (Dave) BoyerChief Level Officer
Sell
Regular sell transaction (market)
3,461$121.88$421,828.061,672
15 August 2024
William H. (Bill) RastetterChairman of the Board
Sell
Regular sell transaction (market)
14,250$146.69$2,090,332.5037,491
13 August 2024
Gary A LyonsIndependent Director
Sell
Option/Award related
11,570$150.43$1,740,449.65119,047
13 August 2024
Mathew C AbernethyCFO
Sell
Option/Award related
14,100$150.38$2,120,346.7231,528
13 August 2024
Ingrid DelaetChief Level Officer
Sell
Option/Award related
3,043$150.13$456,847.116,607
13 August 2024
Ingrid DelaetChief Level Officer
Sell
Regular sell transaction (market)
4,100$150.08$615,333.332,507
6 August 2024
Ingrid DelaetChief Level Officer
Sell
Option/Award related
273$147.70$40,322.106,607

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 January 2024
Kevin Charles GormanCEO
Sell
Option/Award related
105,835$132.44$14,016,522.81499,754
14 March 2024
Eric S. BenevichChief Level Officer
Sell
Option/Award related
69,521$139.38$9,689,760.5140,778
2 January 2024
Kyle W. GanoChief Level Officer
Sell
Option/Award related
68,884$131.47$9,056,289.69130,250
9 January 2024
Kevin Charles GormanCEO
Sell
Option/Award related
62,023$134.01$8,311,894.50499,754
28 February 2024
Eric S. BenevichChief Level Officer
Sell
Option/Award related
53,143$134.69$7,157,729.7040,616

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.